José Manuel Porcel Pérez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
José Manuel Porcel Pérez has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Manuel Vives
7 shared publications- Alfredo Jover-Sáenz
Unidad Territorial Infección Nosocomial (UTIN), Hospital Universitari Arnau de Vilanova de Lleida (HUAV), Institut de Recerca Biomèdica (IRBLleida), 25198 Lleida, Spain
6 shared publications M Rubio-Caballero
3 shared publications- Aureli Esquerda
Servicio de Análisis Clínicos, Hospital Universitario Arnau de Vilanova, IRBLLEIDA, Lleida, España
2 shared publications M C Rivas
2 shared publicationsM Rubio
2 shared publications
Latest Publications
- 10 May 2008
- Vol. 46 (10) , 637-8
[Transitory hiperamylasemia due to intracranial surgery].
- 22 March 2004
- Published by S. Karger AG in Respiration
- Vol. 71 (2) , 191
Tuberculous Empyema necessitatis
- 22 March 2004
- Published by S. Karger AG in Respiration
- Vol. 71 (2) , 191
Tuberculous Empyema necessitatis
- 1 March 2004
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (6) , 417-420
Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure
- 1 March 2004
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (6) , 417-420
Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure
- Open Access
- 1 March 2004
- Published by SciELO Espana/Repisalud in Anales de Medicina Interna
- Vol. 21 (3) , 17-21
Puntos de corte de los parámetros bioquímicos del líquido pleural: su utilidad en el diagnóstico diferencial de 1.040 pacientes con derrame pleural
The aim of biochemical pleural fluid testing is to reach an etiological diagnosis of the pleural effusion. We assessed the utility of considering cuttoff points for the wide range of analytes used to investigate pleural fluid. Among 1,040 patients with pleural effusion, we sought the etiologies of those fluids which showed any of the following characteristics: red blood cell count = 10 x 109/L, leukocytes = 10 x 109/L, percentage of neutrophils or lymphocytes >50%, protein = 50 g/L, glucose = 60 mg/dL, pH = 7.2, lactate dehydrogenase = 1,000 U/L, adenosine deaminase = 40 U/L, amylase = 100 U/L or cholesterol = 60 mg/dL. Some of the more prominent findings were: a) a sixth of transudates were blood-tinged or contained predominantly neutrophils; b) a groosly bloody fluid suggests malignant disease, trauma, or pulmonary embolization; c) nearly 90% of fluids containing = 10 x 10(9) leukocytes/L were parapneumonics; d) 73% of tuberculous pleural fluids had protein > or = 50 g/L, e) tuberculosis and parapneumonics explained more than 90% of fluids with high adenosine deaminase content; f) one third of amylase-rich pleural effusions were malignant; g) a low pleural glucose or pH levels indicate that patient probably has a parapneumonic, tuberculous or malignant etiology; y h) the diagnostic yield of pleural fluid cytology in malignant effusions was 57%, a percentage which raised to 94% in those with low glucose fluid level. Cuttof values of biochemical pleural fluid tests may greatly support particular causes of pleural effusions.
- 1 March 2004
- Published by SciELO Espana/Repisalud in Anales de Medicina Interna
- Vol. 21 (3) , 17-21
Open AccessPuntos de corte de los parámetros bioquímicos del líquido pleural: su utilidad en el diagnóstico diferencial de 1.040 pacientes con derrame pleural
The aim of biochemical pleural fluid testing is to reach an etiological diagnosis of the pleural effusion. We assessed the utility of considering cuttoff points for the wide range of analytes used to investigate pleural fluid. Among 1,040 patients with pleural effusion, we sought the etiologies of those fluids which showed any of the following characteristics: red blood cell count = 10 x 109/L, leukocytes = 10 x 109/L, percentage of neutrophils or lymphocytes >50%, protein = 50 g/L, glucose = 60 mg/dL, pH = 7.2, lactate dehydrogenase = 1,000 U/L, adenosine deaminase = 40 U/L, amylase = 100 U/L or cholesterol = 60 mg/dL. Some of the more prominent findings were: a) a sixth of transudates were blood-tinged or contained predominantly neutrophils; b) a groosly bloody fluid suggests malignant disease, trauma, or pulmonary embolization; c) nearly 90% of fluids containing = 10 x 10(9) leukocytes/L were parapneumonics; d) 73% of tuberculous pleural fluids had protein > or = 50 g/L, e) tuberculosis and parapneumonics explained more than 90% of fluids with high adenosine deaminase content; f) one third of amylase-rich pleural effusions were malignant; g) a low pleural glucose or pH levels indicate that patient probably has a parapneumonic, tuberculous or malignant etiology; y h) the diagnostic yield of pleural fluid cytology in malignant effusions was 57%, a percentage which raised to 94% in those with low glucose fluid level. Cuttof values of biochemical pleural fluid tests may greatly support particular causes of pleural effusions.
- 1 September 2003
- Vol. 39 (9)
[Primary pulmonary lymphoma with pleural involvement as the first sign of adquired immunodeficiency syndrome].
- 1 September 2003
- Vol. 39 (9)
[Primary pulmonary lymphoma with pleural involvement as the first sign of adquired immunodeficiency syndrome].
- 1 May 2003
- Vol. 9 (5) , CR175-80
Differentiating tuberculous from malignant pleural effusions: a scoring model.
Patients with tuberculous or malignant pleural effusions frequently have similar clinical manifestations and pleural fluid profile. The aim of our study was to derive a simple clinical score for differential diagnosis of these two clinical entities. Our retrospective study involved 106 patients with tuberculous pleurisy and 286 with malignant effusions, seen during a 9-year period. Clinical and laboratory variables with (model 1) and without (model 2) the addition of pleural adenosine deaminase entered into a multivariate analysis to calculate a scoring system (range 0 to 10) for the detection of tuberculous effusions. In model 1, four variables predicted a tuberculous etiology: adenosine deaminase > or = 40 U/L (5 points), age or 37.8 degrees C (2), and pleural fluid red blood cell count < 5 x 10(9)/L (1). In addition to the last three items, model 2 identified other predictive parameters: no history of malignancy (3), pleural protein > or = 50 g/L (1), and pleural fluid to serum lactate dehydrogenase ratio > or 2.2 (1). Summated scores of > or 5 in model 1 and > or 6 in model 2 yielded measures of sensitivity (95% and 97%), and specificity (94% and 91%) for discriminating tuberculous from malignant effusions, respectively. The area under the ROC curve for models 1 and 2 was 0.987 and 0.982, respectively. The combination of clinical data and pleural fluid chemistry profile into a score-based model can facilitate differential diagnosis between tuberculous and malignant effusions.
- 1 May 2003
- Vol. 9 (5) , CR175-80
Differentiating tuberculous from malignant pleural effusions: a scoring model.
Patients with tuberculous or malignant pleural effusions frequently have similar clinical manifestations and pleural fluid profile. The aim of our study was to derive a simple clinical score for differential diagnosis of these two clinical entities. Our retrospective study involved 106 patients with tuberculous pleurisy and 286 with malignant effusions, seen during a 9-year period. Clinical and laboratory variables with (model 1) and without (model 2) the addition of pleural adenosine deaminase entered into a multivariate analysis to calculate a scoring system (range 0 to 10) for the detection of tuberculous effusions. In model 1, four variables predicted a tuberculous etiology: adenosine deaminase > or = 40 U/L (5 points), age or 37.8 degrees C (2), and pleural fluid red blood cell count < 5 x 10(9)/L (1). In addition to the last three items, model 2 identified other predictive parameters: no history of malignancy (3), pleural protein > or = 50 g/L (1), and pleural fluid to serum lactate dehydrogenase ratio > or 2.2 (1). Summated scores of > or 5 in model 1 and > or 6 in model 2 yielded measures of sensitivity (95% and 97%), and specificity (94% and 91%) for discriminating tuberculous from malignant effusions, respectively. The area under the ROC curve for models 1 and 2 was 0.987 and 0.982, respectively. The combination of clinical data and pleural fluid chemistry profile into a score-based model can facilitate differential diagnosis between tuberculous and malignant effusions.
- 1 January 2003
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 39 (9) , 433-434
Linfoma pulmonar primario con afectación pleural como manifestacion inicial de sida
- 1 January 2003
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 39 (9) , 433-434
Linfoma pulmonar primario con afectación pleural como manifestacion inicial de sida
- 1 January 2003
- Published by Elsevier in FMC - Formación Médica Continuada en Atención Primaria
- Vol. 10 (7) , 517-518
Neumonía lipoidea aguda profesional
- 1 January 2003
- Published by Elsevier in FMC - Formación Médica Continuada en Atención Primaria
- Vol. 10 (7) , 517-518
Neumonía lipoidea aguda profesional